Regulation of TLR2-mediated tolerance and cross-tolerance through irak4 modulation by mir-132 and mir-212

Journal of Immunology

Volumn 190, Issue 3, 2013, Pages 1250-1263

  Nahid, Md A ^a   Yao, Bing ^b   Dominguez Gutierrez, Paul R ^a   Kesavalu, Lakshmyya ^b   Satoh, Minoru ^b,c   Chan, Edward K L ^a,c  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FLAGELLIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; LIPOPOLYSACCHARIDE; MICRORNA; MICRORNA 132; MICRORNA 146A; MIR 212; MYELOID DIFFERENTIATION FACTOR 88; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; CROSS TOLERANCE; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BACTERIAL PROTEINS; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FEMALE; FLAGELLIN; GENE EXPRESSION REGULATION; GENES, REPORTER; IMMUNE TOLERANCE; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICRORNAS; MONOCYTES; MYELOID DIFFERENTIATION FACTOR 88; PEPTIDOGLYCAN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84872722692     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103060     Document Type: Article

References (56)

1. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511. (Pubitemid 38931765)
2. Cook, D. N., D. S. Pisetsky, and D. A. Schwartz. 2004. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 5: 975-979. (Pubitemid 41057713)
3. de Vos, A. F., J. M. Pater, P. S. van den Pangaart, M. D. de Kruif, C. van 't Veer, and T. van der Poll. 2009. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands. J. Immunol. 183: 533-542.
4. del Fresno, C., F. García-Rio, V. Gómez-Pina, A. Soares-Schanoski, I. Fernández-Ruíz, T. Jurado, T. Kajiji, C. Shu, E. Marín, A. Gutierrez del Arroyo, et al. 2009. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide- tolerant human monocytes: Demonstration in isolated monocytes from cystic fibrosis patients. J. Immunol. 182: 6494-6507.
5. Foster, S. L., D. C. Hargreaves, and R. Medzhitov. 2007. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978. (Pubitemid 46975746)
6. Liew, F. Y., D. Xu, E. K. Brint, and L. A. O'Neill. 2005. Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5: 446-458. (Pubitemid 40835033)
7. Medvedev, A. E., K. M. Kopydlowski, and S. N. Vogel. 2000. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: Dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression. J. Immunol. 164: 5564-5574. (Pubitemid 30389795)
8. Murphey, E. D., and E. R. Sherwood. 2008. Pretreatment with the Gram-positive bacterial cell wall molecule peptidoglycan improves bacterial clearance and decreases inflammation and mortality in mice challenged with Pseudomonas aeruginosa. Microbes Infect. 10: 1244-1250.
9. Nakayama, K., S. Okugawa, S. Yanagimoto, T. Kitazawa, K. Tsukada M. Kawada, S. Kimura, K. Hirai, Y. Takagaki, and Y. Ota. 2004. Involvement of IRAK-M in peptidoglycan-induced tolerance in macrophages. J. Biol. Chem. 279: 6629-6634. (Pubitemid 38248800)
10. Carpenter, S., and L. A. O'Neill. 2009. Recent insights into the structure of Tolllike receptors and post-translational modifications of their associated signalling proteins. Biochem. J. 422: 1-10.
11. Bowie, A. G. 2008. TRIM-ing down Tolls. Nat. Immunol. 9: 348-350. (Pubitemid 351405103)
12. Jacinto, R., T. Hartung, C. McCall, and L. Li. 2002. Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: Distinct alterations in IL-1 receptor-associated kinase. J. Immunol. 168: 6136-6141. (Pubitemid 34620031)
13. Kobayashi, K., L. D. Hernandez, J. E. Galán, C. A. Janeway, Jr., R. Medzhitov, and R. A. Flavell. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202. (Pubitemid 34876547)
14. Li, L., S. Cousart, J. Hu, and C. E. McCall. 2000. Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J. Biol. Chem. 275: 23340-23345. (Pubitemid 30646236)
15. Sheedy, F. J., E. Palsson-McDermott, E. J. Hennessy, C. Martin, J. J. O'Leary, Q. Ruan, D. S. Johnson, Y. Chen, and L. A. O'Neill. 2010. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol. 11: 141-147.
16. Filipowicz, W., S. N. Bhattacharyya, and N. Sonenberg. 2008. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat. Rev. Genet. 9: 102-114.
17. Baltimore, D., M. P. Boldin, R. M. O'Connell, D. S. Rao, and K. D. Taganov. 2008. MicroRNAs: New regulators of immune cell development and function. Nat. Immunol. 9: 839-845. (Pubitemid 352038302)
18. Hou, J., P. Wang, L. Lin, X. Liu, F. Ma, H. An, Z. Wang, and X. Cao. 2009. MicroRNA-146a feedback inhibits RIG-I-dependent yype I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183: 2150-2158.
19. Ruggiero, T., M. Trabucchi, F. De Santa, S. Zupo, B. D. Harfe, M. T. McManus, M. G. Rosenfeld, P. Briata, and R. Gherzi. 2009. LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages. FASEB J. 23: 2898-2908.
20. Nahid, M. A., M. Satoh, and E. K. L. Chan. 2011. Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J. Immunol. 186: 1723-1734.
21. Nahid, M. A., K. M. Pauley, M. Satoh, and E. K. L. Chan. 2009. miR-146a is critical for endotoxin-induced tolerance: Implication in innate immunity. J. Biol. Chem. 284: 34590-34599.
22. Lin, S. C., Y. C. Lo, and H. Wu. 2010. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465: 885-890.
23. De Nardo, D., T. Nguyen, J. A. Hamilton, and G. M. Scholz. 2009. Downregulation of IRAK-4 is a component of LPS-and CpG DNA-induced tolerance in macrophages. Cell. Signal. 21: 246-252.
24. Suzuki, N., S. Suzuki, G. S. Duncan, D. G. Millar, T. Wada, C. Mirtsos, H. Takada, A. Wakeham, A. Itie, S. Li, et al. 2002. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416: 750-756.
25. Taganov, K. D.,M. P. Boldin, K. J. Chang, and D. Baltimore. 2006. NF-kB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103: 12481-12486. (Pubitemid 44267285)
26. O'Neill, L. A., F. J. Sheedy, and C. E. McCoy. 2011. MicroRNAs: The fine-tuners of Toll-like receptor signalling. Nat. Rev. Immunol. 11: 163-175.
27. Vo, N., M. E. Klein, O. Varlamova, D. M. Keller, T. Yamamoto, R. H. Goodman, and S. Impey. 2005. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc. Natl. Acad. Sci. USA 102: 16426-16431. (Pubitemid 41688930)
28. Remenyi, J., C. J. Hunter, C. Cole, H. Ando, S. Impey, C. E. Monk, K. J. Martin, G. J. Barton, G. Hutvagner, and J. S. Arthur. 2010. Regulation of the miR-212/ 132 locus by MSK1 and CREB in response to neurotrophins. Biochem. J. 428: 281-291.
29. Wayman, G. A., M. Davare, H. Ando, D. Fortin, O. Varlamova, H. Y. Cheng, D. Marks, K. Obrietan, T. R. Soderling, R. H. Goodman, and S. Impey. 2008. An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc. Natl. Acad. Sci. USA 105: 9093-9098.
30. Shaked, I., A. Meerson, Y. Wolf, R. Avni, D. Greenberg, A. Gilboa-Geffen, and H. Soreq. 2009. MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity 31: 965-973.
31. Lagos, D., G. Pollara, S. Henderson, F. Gratrix, M. Fabani, R. S. Milne, F. Gotch, and C. Boshoff. 2010. miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat. Cell Biol. 12: 513-519.
32. Hollander, J. A., H. I. Im, A. L. Amelio, J. Kocerha, P. Bali, Q. Lu, D. Willoughby, C. Wahlestedt, M. D. Conkright, and P. J. Kenny. 2010. Striatal microRNA controls cocaine intake through CREB signalling. Nature 466: 197-202.
33. Incoronato, M., M. Garofalo, L. Urso, G. Romano, C. Quintavalle, C. Zanca, M. Iaboni, G. Nuovo, C. M. Croce, and G. Condorelli. 2010. miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. Cancer Res. 70: 3638-3646.
34. Nahid, A. M., and S. Sugii. 2006. Binding of porcine ficolin-alpha to lipopolysaccharides from Gram-negative bacteria and lipoteichoic acids from Gram-positive bacteria. Dev. Comp. Immunol. 30: 335-343. (Pubitemid 41571273)
35. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDC(T) Method. Methods 25: 402-408. (Pubitemid 34164012)
36. Gupta, D., Q. Wang, C. Vinson, and R. Dziarski. 1999. Bacterial peptidoglycan induces CD14-dependent activation of transcription factors CREB/ATF and AP-1. J. Biol. Chem. 274: 14012-14020.
37. Friedman, R. C., K. K. Farh, C. B. Burge, and D. P. Bartel. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19: 92-105.
38. La Spada, A. R., and J. P. Taylor. 2010. Repeat expansion disease: Progress and puzzles in disease pathogenesis. Nat. Rev. Genet. 11: 247-258.
39. Brown, K. L., R. Falsafi, W. Kum, P. Hamill, J. L. Gardy, D. J. Davidson, S. Turvey, B. B. Finlay, D. P. Speert, and R. E. Hancock. 2010. Robust TLR4-induced gene expression patterns are not an accurate indicator of human immunity. J. Transl. Med. 8: 6.
40. Nahid, M. A., M. Rivera, A. Lucas, E. K. L. Chan, and L. Kesavalu. 2011. Polymicrobial infection with periodontal pathogens specifically enhances microRNA miR-146a in ApoE-/-mice during experimental periodontal disease. Infect. Immun. 79: 1597-1605.
41. Taganov, K. D., M. P. Boldin, and D. Baltimore. 2007. MicroRNAs and immunity: Tiny players in a big field. Immunity 26: 133-137. (Pubitemid 46329443)
42. Nahid, M. A., M. Satoh, and E. K. L. Chan. 2011. MicroRNA in TLR signaling and endotoxin tolerance. Cell. Mol. Immunol. 8: 388-403.
43. Baek, D., J. Villén, C. Shin, F. D. Camargo, S. P. Gygi, and D. P. Bartel. 2008. The impact of microRNAs on protein output. Nature 455: 64-71.
44. Selbach, M., B. Schwanhausser, N. Thierfelder, Z. Fang, R. Khanin, and N. Rajewsky. 2008. Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
45. Dziarski, R., R. I. Tapping, and P. S. Tobias. 1998. Binding of bacterial peptidoglycan to CD14. J. Biol. Chem. 273: 8680-8690. (Pubitemid 28176145)
46. Gupta, D., T. N. Kirkland, S. Viriyakosol, and R. Dziarski. 1996. CD14 is a cellactivating receptor for bacterial peptidoglycan. J. Biol. Chem. 271: 23310-23316. (Pubitemid 26314774)
47. Hsu, L. C., J. M. Park, K. Zhang, J. L. Luo, S. Maeda, R. J. Kaufman, L. Eckmann, D. G. Guiney, and M. Karin. 2004. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428: 341-345. (Pubitemid 38418807)
48. Krutzfeldt, J., N. Rajewsky, R. Braich, K. G. Rajeev, T. Tuschl, M. Manoharan, and M. Stoffel. 2005. Silencing of microRNAs in vivo with 'antagomirs.' Nature 438: 685-689.
49. Tsai, E. Y., J. V. Falvo, A. V. Tsytsykova, A. K. Barczak, A. M. Reimold, L. H. Glimcher, M. J. Fenton, D. C. Gordon, I. F. Dunn, and A. E. Goldfeld. 2000. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol. Cell. Biol. 20: 6084-6094. (Pubitemid 30613056)
50. Ucar, A., V. Vafaizadeh, H. Jarry, J. Fiedler, P. A. Klemmt, T. Thum, B. Groner, and K. Chowdhury. 2010. miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. Nat. Genet. 42: 1101-1108.
51. Dziarski, R. 2004. Peptidoglycan recognition proteins (PGRPs). Mol. Immunol. 40: 877-886. (Pubitemid 38032811)
52. Girardin, S. E., I. G. Boneca, L. A. Carneiro, A. Antignac, M. Jéhanno, J. Viala, K. Tedin, M. K. Taha, A. Labigne, U. Zahringer, et al. 2003. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300: 1584-1587. (Pubitemid 36682892)
53. Mullaly, S. C., and P. Kubes. 2006. The role of TLR2 in vivo following challenge with Staphylococcus aureus and prototypic ligands. J. Immunol. 177: 8154-8163. (Pubitemid 44846335)
54. Anand, S., B. K. Majeti, L. M. Acevedo, E. A. Murphy, R. Mukthavaram, L. Scheppke, M. Huang, D. J. Shields, J. N. Lindquist, P. E. Lapinski, et al. 2010. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat. Med. 16: 909-914.
55. Wada, R., Y. Akiyama, Y. Hashimoto, H. Fukamachi, and Y. Yuasa. 2010. miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer. Int. J. Cancer 127: 1106-1114.
56. Murata, K., H. Yoshitomi, S. Tanida, M. Ishikawa, K. Nishitani, H. Ito, and T. Nakamura. 2010. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res. Ther. 12: R86.